Precision Cancer Care with RGCC
Most cancer treatments are based on what works for the “average” patient, but no two cancers are genetically the same. RGCC (Research Genetics Cancer Center) is a world leader in changing that through precision oncology.
Instead of traditional, invasive biopsies, RGCC uses advanced “liquid biopsies”—a simple blood test that captures circulating tumor cells traveling through your body. In their specialized labs, these cells are tested against over 50 different chemotherapies and natural substances to see exactly which ones effectively kill your specific cancer.
By taking the guesswork out of treatment, RGCC provides a personalized roadmap. This data helps your medical team choose therapies with the highest chance of success while avoiding those your cancer is already resistant to.